Global SPECT Market Driven by the Growing Demand for Early Diagnosis of Diseases: Technavio

Technavio has published a new report on the global SPECT market from 2017-2021. (Graphic: Business Wire)

LONDON--()--According to the latest market study released by Technavio, the global SPECT market is projected to grow to USD 1.5 billion by 2021, at a CAGR of more than 5% during the forecast period.

This research report titled ‘Global SPECT Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.

Single-photon emission computed tomography (SPECT) is a nuclear medicine tomographic imaging technique that involves the generation of images using gamma radiation. The ability of nuclear imaging techniques to accurately detect molecular activity in the body and diagnose diseases in their earliest stage is expected to impact the growth of the global SPECT market positively.

Request a sample report:

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Based on application, the report categorizes the global SPECT market into the following segments:

  • Cardiology
  • Oncology
  • General Imaging
  • Neurology

The top three revenue-generating application segments in the global SPECT market are discussed below:


The cardiology segment of the SPECT market is responsible for generating around 35% of the overall revenue. Cardiac SPECT scans are mainly conducted for the detection of coronary artery diseases, percutaneous coronary intervention (PCI), and other cardiac abnormalities,” says Srinivas Sashidhar, a lead analyst at Technavio for medical imaging research.

The change in lifestyle increased consumption of alcohol, and hypertension is some of the major factors contributing to the high demand for cardiac SPECT imaging. Technological advances allowing for faster scan results, reduced motion artifacts, increased sensitivity, and improved image quality are leading to the growth of the market segment.


SPECT scanners are mainly used in the oncology for the timely detection of cancers such as lung cancer, breast cancer, bowel cancer, and prostate cancer. The rising incidences of various types of cancers have increased the adoption of SPECT scans in the oncology. Since SPECT scanners can perform molecular level imaging, it is more accurate than other imaging techniques, which is aiding in its swift market penetration. Currently, the multi-slice integrated SPECT/CT scanners introduced by GE Healthcare has accelerated market growth.

General imaging

General imaging using SPECT scanners is used for screening the entire body, ranging from the head till the toe. The sensitivity of these scanners, combined with their superior image quality, is driving their growth in the general imaging market segment,” says Srinivas.

General imaging of the breast tissue is one of the most widely adopted techniques in the general imaging market segment, as SPECT imaging provides details that other techniques such as mammography or ultrasound cannot provide. GE Healthcare holds the maximum share of this market space, followed by Siemens Healthineers and Philips Healthcare.

The top vendors highlighted by Technavio’s research analysts in this report are:

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthineers

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like oncology, vaccines, and urology devices. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770

Release Summary

According to the latest market study released by Technavio, the global SPECT market is projected to grow to USD 1.5 billion by 2021, at a CAGR of more than 5% during the forecast period.



Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770